Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study

Advanced TCs harbor a high prevalence of ESCAT I-III AMTs. Patients eligible for clinical trials with experimental drugs should undergo comprehensive genomic profiling and evaluation by an MTB to assess therapeutic actionability. A new biopsy is recommended for formalin-fixed, paraffin-embedded specimens older than 5 years to increase the likelihood of obtaining evaluable results.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-10-29
DOI
https://doi.org/10.1016/j.esmoop.2025.105856
Citations
1
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study

Imperia Nuzzolese, A. Vingiani, Massimo Milione, Silvia Buriolla et al.
1 citations
ESMO Open
Thyroid Cancer Diagnosis and Treatment
1.29
article

Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study

Imperia Nuzzolese, A. Vingiani, Massimo Milione, Silvia Buriolla, Laura D. Locati, Luca Agnelli, Biagio Paolini, Carlo Resteghini, Cristiana Bergamini, I. Capone, Sergio Alfieri, Matteo Duca, Lisa Licitra, Marco Salvetti, F Caspani, Alessandro Piccolo, Giuseppina Calareso, Giancarlo Pruneri, Stefano Cavalieri, Elena Tamborini, Elena Colombo, Arianna Ottini, Franco Perrone
article en
1 citations

Abstract

Advanced TCs harbor a high prevalence of ESCAT I-III AMTs. Patients eligible for clinical trials with experimental drugs should undergo comprehensive genomic profiling and evaluation by an MTB to assess therapeutic actionability. A new biopsy is recommended for formalin-fixed, paraffin-embedded specimens older than 5 years to increase the likelihood of obtaining evaluable results.

ESMO OpenVol. 10(11)
Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Openalex Percentile: Top 14%
Thyroid Cancer Diagnosis and Treatment
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.